# Immediate Release Versus Slow Release Carvedilol in Heart Failure

> **NCT03209180** · PHASE4 · UNKNOWN · sponsor: **Seoul National University Bundang Hospital** · enrollment: 320 (estimated)

## Conditions studied

- Heart Failure With Reduced Ejection Fraction

## Interventions

- **DRUG:** CarVeDilol-SR (Slow Release)
- **DRUG:** Carvedilol IR (Immediate Release)

## Key facts

- **NCT ID:** NCT03209180
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10-27
- **Primary completion:** 2018-06-25
- **Final completion:** 2018-12-31
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2017-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03209180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03209180, "Immediate Release Versus Slow Release Carvedilol in Heart Failure". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03209180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*